Who Paid My Doc
Triptodur
Drug Pediatrics/Neonatology
NDC 24338-150-20
General payments
$109,859
Research payments
$23,500
Through program year 2023, $109,859 in general payments and $23,500 in research payments were reported against Triptodur (Pediatrics/Neonatology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $22,147 | 837 |
| 2022 | General | $8,952 | 317 |
| 2022 | Research | $3,125 | 4 |
| 2021 | General | $14,057 | 372 |
| 2021 | Research | $20,375 | 20 |
| 2020 | General | $64,702 | 323 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 34 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
1,849 general · 24 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.